The Board Directors of Milestone Medical Inc. (“the Company”, “the Issuer”) informs that on May 23, 2017 the Annual General Meeting of Shareholders adopted the resolution on the approval and ratification of Friedman LLP as an entity authorised to audit consolidated financial statements of the Company for the fiscal year 2017. Friedman LLP was approved and recommended as independent auditor by the Audit Committee of the Board.
§3 section 1 point 11) of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodic Information in the Alternative System on the NewConnect Market”
Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer